Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

INNOHEP

LEO PHARMA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of INNOHEP in Canada?

A shortage of INNOHEP 20000UNIT is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 7, 2026), but it has not started yet.

Why is INNOHEP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will INNOHEP be available again?

The manufacturer's estimated resolution date is October 16, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file3 products
Expected resolution~18 days remaining (estimate)
Affected strength20000UNIT
Last updated2026-08-07

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

LOGIPARIN LIQ SC 10000 FXAIU/ML

NOVO NORDISK CANADA INC

10000UNIT · DIN 02056682

Different strengthDifferent dosage formSame routeNo current shortage

INNOHEP

LEO PHARMA INC

10000UNIT · DIN 02167840

Different strengthSame dosage formSame routeNo current shortage

INNOHEP DISP.SYR.-11700 ANTI-XA IU/ML

LEO PHARMA INC

11700UNIT · DIN 02167859

Different strengthDifferent dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02229515

Strength

20000UNIT

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

TINZAPARIN SODIUM

See all TINZAPARIN SODIUM products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History